kabutan

TEIJIN LIMITED(3401) Summary

3401
TSE Prime
TEIJIN LIMITED
1,466.0
JPY
+6.0
(+0.41%)
Jan 29, 3:30 pm JST
9.58
USD
Jan 29, 1:30 am EST
Result
PTS
outside of trading hours
Summary Chart Historical News Financial Result
PER
PBR
0.74
Yield
3.41%
Margin Trading Ratio
8.54
Stock Price
Jan 29, 2026
Opening Jan 29, 9:00 am
1,450.0 JPY 9.47 USD
Previous Close Jan 28
1,460.0 JPY 9.56 USD
High Jan 29, 3:02 pm
1,472.0 JPY 9.61 USD
Low Jan 29, 9:00 am
1,447.5 JPY 9.45 USD
Volume
641,000
Trading Value
0.94B JPY 6.13M USD
VWAP
1462.52 JPY 9.56 USD
Minimum Trading Value
146,600 JPY 958 USD
Market Cap
0.29T JPY 1.91B USD
Number of Trades
1,573
Liquidity & Number of Trades
As of Jan 29, 2026
Liquidity
High
1-Year Average
1,782
1-Year High Nov 5, 2025
8,979
Margin Trading
Date Short Interest Long Margin Positions Ratio
Jan 23, 2026 172,400 2,096,600 12.16
Jan 16, 2026 168,900 2,111,000 12.50
Jan 9, 2026 169,300 2,146,000 12.68
Dec 26, 2025 173,400 2,074,500 11.96
Dec 19, 2025 167,600 2,094,600 12.50
Company Profile
TEIJIN LIMITED is a major synthetic fiber manufacturer, ranking second globally in carbon fiber production. The company's three main pillars are synthetic fibers, chemical products, and pharmaceuticals/medical care. It also has a presence in the healthcare sector.
Sector
Texstiles & Apparels
TEIJIN LIMITED operates in various business segments including materials, fibers & products, healthcare, and IT. In its materials business, the company manufactures and sells high-performance materials such as aramid fibers, resins, and carbon fibers, as well as composite materials. The fibers & products division focuses on the manufacture and sale of fiber products, polyester fibers, and textiles. In healthcare, TEIJIN LIMITED manufactures and sells pharmaceuticals and medical devices, while also providing home healthcare services. The IT business segment offers information system operation, development, and maintenance services, as well as electronic comic distribution. Additionally, the company manufactures and sells battery materials and membranes, and develops, manufactures, and sells regenerative medicine products and implantable medical devices.